Sumanta K. Pal Discusses Strides Made in Kidney Cancer Care

Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the great strides in kidney cancer care that have been made in the past decade.

Throughout the past 10 years, treatment for kidney cancer has continued to evolve, with at least seven new targeted therapies approved, making the survival rate triple. Also, Pal notes that doctors are bringing back immune-based treatment in more targeted and specific ways, which he believes will further improve survival rates for the disease.